Distinct composition of human fetal HDL attenuates its anti-oxidative capacity

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 4, 2013, Pages 737-746

  Sreckovic, Ivana ^a   Birner Gruenberger, Ruth ^a   Obrist, Britta ^a   Stojakovic, Tatjana ^a   Scharnagl, Hubert ^a   Holzer, Michael ^a   Scholler, Monika ^a   Philipose, Sonia ^a   Marsche, Gunther ^a   Lang, Uwe ^a   Desoye, Gernot ^a   Wadsack, Christian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Antioxidative capacity; Apolipoprotein; Fetal HDL; PON1

Indexed keywords

APOENZYME; APOFERRITIN; ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID; HIGH DENSITY LIPOPROTEIN 3; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; TRIACYLGLYCEROL;

ANTIOXIDANT ACTIVITY; ARTICLE; CESAREAN SECTION; CHEMICAL ANALYSIS; ENZYME ACTIVITY; FEMALE; FETUS; FETUS CIRCULATION; HUMAN; INNATE IMMUNITY; LIPID COMPOSITION; LIQUID CHROMATOGRAPHY; MATERNAL BLOOD; PREGNANCY; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TERM BIRTH; UMBILICAL CORD BLOOD;

APOLIPOPROTEINS; APOLIPOPROTEINS C; APOLIPOPROTEINS D; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; FETUS; HUMANS; LIPOPROTEINS, HDL; PREGNANCY;

EID: 84873456846     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.12.015     Document Type: Article

References (69)

1. S. Bastida, F.J. Sanchez-Muniz, C. Cuesta, S. Perea, and A. Aragones Male and female cord blood lipoprotein profile differences throughout the term-period J. Perinat. Med. 25 1997 184 191
2. M.R. Averna, C.M. Barbagallo, G. Di Paola, M. Labisi, G. Pinna, G. Marino, U. Dimita, and A. Notarbartolo Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns Biol. Neonate 60 1991 187 192
3. P.J. Dolphin, W.C. Breckenridge, M.A. Dolphin, and M.H. Tan The lipoproteins of human umbilical cord blood apolipoprotein and lipid levels Atherosclerosis 51 1984 109 122
4. H. Merzouk, M. Meghelli-Bouchenak, N. el-Korso, J. Belleville, and J. Prost Low birth weight at term impairs cord serum lipoprotein compositions and concentrations Eur. J. Pediatr. 157 1998 321 326
5. N. Saha Serum high density lipoprotein cholesterol, apolipoprotein A-I, A-II and B levels in Singapore ethnic groups Atherosclerosis 68 1987 117 121
6. A. Kontush, and M.J. Chapman Antiatherogenic small, dense HDL-guardian angel of the arterial wall? Nat. Clin. Pract. Cardiovasc. Med. 3 2006 144 153
7. W.S. Davidson, and T.B. Thompson The structure of apolipoprotein A-I in high density lipoproteins J. Biol. Chem. 282 2007 22249 22253
8. D.M. Lane, and W.J. McConathy Changes in the serum lipids and apolipoproteins in the first four weeks of life Pediatr. Res. 20 1986 332 337
9. L. Gaidukov, R.I. Viji, S. Yacobson, M. Rosenblat, M. Aviram, and D.S. Tawfik ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I Biochemistry 49 2010 532 538
10. Y. Zhao, F.E. Thorngate, K.H. Weisgraber, D.L. Williams, and J.S. Parks Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins Biochemistry 44 2005 1013 1025
11. A. Kontush, and M.J. Chapman Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis Pharmacol. Rev. 58 2006 342 374
12. M. Aviram, M. Rosenblat, C.L. Bisgaier, R.S. Newton, S.L. Primo-Parmo, and B.N. La Du Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase J. Clin. Invest. 101 1998 1581 1590
13. H. Berrougui, S. Loued, and A. Khalil Purified human paraoxonase-1 interacts with plasma membrane lipid rafts and mediates cholesterol efflux from macrophages Free Radic. Biol. Med. 52 2012 1372 1381
14. D.I. Draganov, J.F. Teiber, A. Speelman, Y. Osawa, R. Sunahara, and B.N. La Du Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities J. Lipid Res. 46 2005 1239 1247
15. C.J. Ng, D.M. Shih, S.Y. Hama, N. Villa, M. Navab, and S.T. Reddy The paraoxonase gene family and atherosclerosis Free Radic. Biol. Med. 38 2005 153 163
16. G.A. Francis The complexity of HDL Biochim. Biophys. Acta 1801 2010 1286 1293
17. K.A. Rye, and P.J. Barter Predictive value of different HDL particles for the protection against or risk of coronary heart disease Biochim. Biophys. Acta 1821 2012 473 480
18. T. Vaisar, S. Pennathur, P.S. Green, S.A. Gharib, A.N. Hoofnagle, M.C. Cheung, J. Byun, S. Vuletic, S. Kassim, P. Singh, H. Chea, R.H. Knopp, J. Brunzell, R. Geary, A. Chait, X.Q. Zhao, K. Elkon, S. Marcovina, P. Ridker, J.F. Oram, and J.W. Heinecke Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL J. Clin. Invest. 117 2007 746 756
19. G. Desoye, M.O. Schweditsch, K.P. Pfeiffer, R. Zechner, and G.M. Kostner Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum J. Clin. Endocrinol. Metab. 64 1987 704 712
20. V.K. Misra, S. Trudeau, and U. Perni Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI Obesity (Silver Spring) 19 2011 1476 1481
21. G.O. Taylor, J.J. Albers, G.R. Warnick, J.L. Adolphson, H. McFarlane, D.R. Sullivan, C.E. West, V. Sri-Hari, and R. Edwards Studies of lipoproteins and fatty acids in maternal and cord blood of two racial groups in Trinidad Lipids 22 1987 173 177
22. A. Basu, P. Alaupovic, M. Wu, A.J. Jenkins, Y. Yu, A.J. Nankervis, K.F. Hanssen, H. Scholz, T. Henriksen, B. Lorentzen, T. Clausen, S.K. Garg, M.K. Menard, S.M. Hammad, J.A. Scardo, J.R. Stanley, A. Dashti, C.E. Aston, and T.J. Lyons Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study J. Clin. Endocrinol. Metab. 97 2012 1752 1762
23. U. Martin, C. Davies, S. Hayavi, A. Hartland, and F. Dunne Is normal pregnancy atherogenic? Clin. Sci. (Lond.) 96 1999 421 425
24. A. Montelongo, M.A. Lasuncion, L.F. Pallardo, and E. Herrera Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women Diabetes 41 1992 1651 1659
25. N. Sattar, I.A. Greer, J. Louden, G. Lindsay, M. McConnell, J. Shepherd, and C.J. Packard Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein J. Clin. Endocrinol. Metab. 82 1997 2483 2491
26. W. Palinski, E. Nicolaides, A. Liguori, and C. Napoli Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease J. Cardiovasc. Transl. Res. 2 2009 277 285
27. W. Palinski, T. Yamashita, S. Freigang, and C. Napoli Developmental programming: maternal hypercholesterolemia and immunity influence susceptibility to atherosclerosis Nutr. Rev. 65 2007 S182 S187
28. R.H. Neary, M.D. Kilby, P. Kumpatula, F.L. Game, D. Bhatnagar, P.N. Durrington, and P.M. O'Brien Fetal and maternal lipoprotein metabolism in human pregnancy Clin. Sci. (Lond.) 88 1995 311 318
29. M.D. Kilby, R.H. Neary, M.I. Mackness, and P.N. Durrington Fetal and maternal lipoprotein metabolism in human pregnancy complicated by type I diabetes mellitus J. Clin. Endocrinol. Metab. 83 1998 1736 1741
30. V.A. Rodie, M.J. Caslake, F. Stewart, N. Sattar, J.E. Ramsay, I.A. Greer, and D.J. Freeman Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction Atherosclerosis 176 2004 181 187
31. W. Sattler, D. Mohr, and R. Stocker Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence Methods Enzymol. 233 1994 469 489
32. C. Wadsack, A. Hrzenjak, A. Hammer, B. Hirschmugl, S. Levak-Frank, G. Desoye, W. Sattler, and E. Malle Trophoblast-like human choriocarcinoma cells serve as a suitable in vitro model for selective cholesteryl ester uptake from high density lipoproteins Eur. J. Biochem. 270 2003 451 462
33. D.H. Lundgren, S.I. Hwang, L. Wu, and D.K. Han Role of spectral counting in quantitative proteomics Expert Rev. Proteomics 7 2010 39 53
34. W.M. Old, K. Meyer-Arendt, L. Aveline-Wolf, K.G. Pierce, A. Mendoza, J.R. Sevinsky, K.A. Resing, and N.G. Ahn Comparison of label-free methods for quantifying human proteins by shotgun proteomics Mol. Cell. Proteomics 4 2005 1487 1502
35. P.J. Blanche, E.L. Gong, T.M. Forte, and A.V. Nichols Characterization of human high-density lipoproteins by gradient gel electrophoresis Biochim. Biophys. Acta 665 1981 408 419
36. Y. Ashida, A. Takagi, and Y. Ikeda Improved method for non-denaturing polyacrylamide gradient gel electrophoresis for detection of small-sized LDL produced during postprandial hypertriglyceridaemia Scand. J. Clin. Lab. Invest. 59 1999 663 670
37. S.P. Gieseg, and H. Esterbauer Low density lipoprotein is saturable by pro-oxidant copper FEBS Lett. 343 1994 188 194
38. H. Nagasaka, H. Chiba, H. Kikuta, H. Akita, Y. Takahashi, H. Yanai, S.P. Hui, H. Fuda, H. Fujiwara, and K. Kobayashi Unique character and metabolism of high density lipoprotein (HDL) in fetus Atherosclerosis 161 2002 215 223
39. M. Szpakowski, M. Nowak, P. Oszukowski, A. Wieczorek, and A. Skotnicka C-reactive protein in normal pregnancy Ginekol. Pol. 67 1996 17 20
40. M. Holzer, R. Birner-Gruenberger, T. Stojakovic, D. El-Gamal, V. Binder, C. Wadsack, A. Heinemann, and G. Marsche Uremia alters HDL composition and function J. Am. Soc. Nephrol. 22 2011 1631 1641
41. C.B. Gilks, S.E. Bear, H.L. Grimes, and P.N. Tsichlis Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein Mol. Cell. Biol. 13 1993 1759 1768
42. D. Nakajima, N. Okazaki, H. Yamakawa, R. Kikuno, O. Ohara, and T. Nagase Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones DNA Res. 9 2002 99 106
43. K. Takahashi, N. Yoshida, N. Murakami, K. Kawata, H. Ishizaki, M. Tanaka-Okamoto, J. Miyoshi, A.R. Zinn, H. Shime, and N. Inoue Dynamic regulation of p53 subnuclear localization and senescence by MORC3 Mol. Biol. Cell 18 2007 1701 1709
44. J. Stefulj, U. Panzenboeck, T. Becker, B. Hirschmugl, C. Schweinzer, I. Lang, G. Marsche, A. Sadjak, U. Lang, G. Desoye, and C. Wadsack Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1 Circ. Res. 104 2009 600 608
45. M. Scholler, C. Wadsack, J. Metso, A.P. Chirackal Manavalan, I. Sreckovic, C. Schweinzer, U. Hiden, M. Jauhiainen, G. Desoye, and U. Panzenboeck Phospholipid transfer protein is differentially expressed in human arterial and venous placental endothelial cells and enhances cholesterol efflux to fetal HDL J. Clin. Endocrinol. Metab. 97 2012 2466 2474
46. M. Augsten, H. Hackl, B. Ebner, A. Chemelli, O. Glatter, G. Marsche, U. Lang, G. Desoye, and C. Wadsack Fetal HDL/apoE: a novel regulator of gene expression in human placental endothelial cells Physiol. Genomics 43 2011 1255 1262
47. N. Saha, and H.B. Wong Serum HDL cholesterol and apolipoprotein AI, AII and B levels in Singapore newborns Biol. Neonate 52 1987 93 96
48. C. Rosales, D. Tang, B.K. Gillard, H.S. Courtney, and H.J. Pownall Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo Arterioscler. Thromb. Vasc. Biol. 31 2011 1834 1841
49. R.W. Mahley, Y. Huang, and K.H. Weisgraber Putting cholesterol in its place: apoE and reverse cholesterol transport J. Clin. Invest. 116 2006 1226 1229
50. N. Bellanger, Z. Julia, E.F. Villard, P. El Khoury, E. Duchene, M.J. Chapman, N. Fournier, W. Le Goff, and M. Guerin Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy Atherosclerosis 221 2012 160 168
51. R. Musanti, L. Giorgini, P.P. Lovisolo, A. Pirillo, A. Chiari, and G. Ghiselli Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells J. Lipid Res. 37 1996 1 14
52. A. Steinmetz, and G. Utermann Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV J. Biol. Chem. 260 1985 2258 2264
53. M.S. Boguski, N. Elshourbagy, J.M. Taylor, and J.I. Gordon Rat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid segment with amphipathic helical potential Proc. Natl. Acad. Sci. U. S. A. 81 1984 5021 5025
54. A.M. Shiflett, J.R. Bishop, A. Pahwa, and S.L. Hajduk Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes J. Biol. Chem. 280 2005 32578 32585
55. M.R. Rifkin Identification of the trypanocidal factor in normal human serum: high density lipoprotein Proc. Natl. Acad. Sci. U. S. A. 75 1978 3450 3454
56. S.L. Hajduk, D.R. Moore, J. Vasudevacharya, H. Siqueira, A.F. Torri, E.M. Tytler, and J.D. Esko Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein J. Biol. Chem. 264 1989 5210 5217
57. K.R. Feingold, and C. Grunfeld The role of HDL in innate immunity J. Lipid Res. 52 2011 1 3
58. M.C. Cheung, and J.J. Albers Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II J. Lipid Res. 23 1982 747 753
59. E.J. Schaefer, D.M. Foster, L.L. Jenkins, F.T. Lindgren, M. Berman, R.I. Levy, and H.B. Brewer Jr. The composition and metabolism of high density lipoprotein subfractions Lipids 14 1979 511 522
60. E.J. Schaefer, and B.F. Asztalos Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction Am. J. Cardiol. 100 2007 n25 n31
61. E.A. Podrez Anti-oxidant properties of high-density lipoprotein and atherosclerosis Clin. Exp. Pharmacol. Physiol. 37 2010 719 725
62. M. Aviram, E. Hardak, J. Vaya, S. Mahmood, S. Milo, A. Hoffman, S. Billicke, D. Draganov, and M. Rosenblat Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities Circulation 101 2000 2510 2517
63. S. Elsoe, J. Ahnstrom, C. Christoffersen, A.N. Hoofnagle, P. Plomgaard, J.W. Heinecke, C.J. Binder, H. Bjorkbacka, B. Dahlback, and L.B. Nielsen Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL Atherosclerosis 221 2012 91 97
64. E. Schnitzer, I. Pinchuk, A. Bor, M. Fainaru, and D. Lichtenberg The effect of albumin on copper-induced LDL oxidation Biochim. Biophys. Acta 1344 1997 300 311
65. F. Rezaee, B. Casetta, J.H. Levels, D. Speijer, and J.C. Meijers Proteomic analysis of high-density lipoprotein Proteomics 6 2006 721 730
66. R.L. Gundry, Q. Fu, C.A. Jelinek, J.E. Van Eyk, and R.J. Cotter Investigation of an albumin-enriched fraction of human serum and its albuminome Proteomics Clin. Appl. 1 2007 73 88
67. M. Heller, D. Stalder, E. Schlappritzi, G. Hayn, U. Matter, and A. Haeberli Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins Proteomics 5 2005 2619 2630
68. W.S. Davidson, R.A. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, and A. Kontush Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function Arterioscler. Thromb. Vasc. Biol. 29 2009 870 876
69. U. Hiden, E. Glitzner, M. Hartmann, and G. Desoye Insulin and the IGF system in the human placenta of normal and diabetic pregnancies J. Anat. 215 2009 60 68